XML 83 R71.htm IDEA: XBRL DOCUMENT v3.20.4
Note 15 - Notes Payable (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Dec. 10, 2020
Nov. 01, 2020
Jan. 09, 2020
Feb. 27, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Gain (Loss) on Exchange of Debt         $ (257,559) $ (257,559)
Conversion of Debt to Common Stock [Member]                
Debt Conversion, Converted Instrument, Shares Issued (in shares) 130,081              
Gain (Loss) on Exchange of Debt $ 300,000              
Debt Conversion, Original Debt, Amount $ 800,000              
Notes Payable, Other Payables [Member]                
Debt Instrument, Face Amount       $ 800,000        
Proceeds from Notes Payable, Total       $ 600,000        
Debt Instrument, Term (Month)   240 days            
Debt Instrument, Unamortized Discount (Premium), Net, Total   $ 200,000            
Amortization of Debt Discount (Premium)         15,000 $ 0 70,000 $ 0
Notes Payable, Other Payables [Member] | Innovus Pharmaceuticals [Member]                
Debt Instrument, Face Amount     $ 500,000          
Proceeds from Notes Payable, Total     $ 400,000          
Debt Instrument, Term (Month)     1 year          
Debt Instrument, Periodic Payment, Total     $ 45,000          
Notes Payable, Total         $ 41,000   $ 41,000